Patient-Reported Safety Information: A Renaissance of Pharmacovigilance?

Härmark, Linda; Raine, June; Leufkens, Hubert; Edwards, I Ralph; Moretti, Ugo; Sarinic, Viola Macolic; Kant, Agnes

Härmark, Linda; Raine, June; Leufkens, Hubert; Edwards, I Ralph; Moretti, Ugo; Sarinic, Viola Macolic; Kant, Agnes.

Affiliation

Härmark L; Netherlands Pharmacovigilance Centre Lareb, WHO Collaborating Center for Pharmacovigilance in Education and Patient Reporting, Goudsbloemvallei 7, 5237 MH, 's-Hertogenbosch, The Netherlands. l.harmark@lareb.nl.
Raine J; Medicines and Healthcare Products Regulatory Agency, 151 Buckingham Palace Road, London, SW1W 9SZ, UK.
Leufkens H; Medicines Evaluation Board, Postbus 8275, 3503 RG, Utrecht, The Netherlands.
Edwards IR; Uppsala Monitoring Centre, Box 1051, 751 40, Uppsala, Sweden.
Moretti U; Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
Sarinic VM; Halmed, Ksaverska cesta 4, 10 000, Zagreb, Croatia.
Kant A; Netherlands Pharmacovigilance Centre Lareb, WHO Collaborating Center for Pharmacovigilance in Education and Patient Reporting, Goudsbloemvallei 7, 5237 MH, 's-Hertogenbosch, The Netherlands.

Drug Saf ; 39(10): 883-90, 2016 10.

Article in En | MEDLINE | ID: mdl-27379887

Subject(s)

Adverse Drug Reaction Reporting Systems/legislation & jurisprudence; Pharmacovigilance; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; European Union; Humans; Patient Reported Outcome Measures

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adverse Drug Reaction Reporting Systems / Pharmacovigilance Type of study: Prognostic_studies Aspects: Patient_preference Limits: Humans Language: En Journal: Drug Saf Journal subject: TERAPIA POR MEDICAMENTOS / TOXICOLOGIA Year: 2016 Document type: Article Affiliation country: Netherlands Country of publication: New Zealand

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google